New Deal Anchors AndroGel Antitrust Suit To Pa., Buyers Say

By Matt Fair · November 22, 2019, 6:21 PM EST

In a move that could impact a bid to transfer an antitrust suit against AndroGel maker AbbVie Inc. and its affiliates from Pennsylvania to multidistrict litigation in Georgia, a group of...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Notice

Case Information

Case Title

KING DRUG COMPANY OF FLORENCE, INC. et al v. ABBOTT LABORATORIES et al

Case Number

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Anti-Trust

Date Filed

August 07, 2019

Recent Articles By Matt

October 20, 2021
Pa. Justices Mull Damages Retrial In $6.3M Med Mal Case
October 19, 2021
Suit Says Pa. Firm Missed Red Flags In Nursing Home Sale
October 12, 2021
High Court Snubs Appeal Over Philly Safe Injection Site
September 30, 2021
Full Pa. Panel OKs $10M Award In Surgery Patient's Death Suit
September 30, 2021
EEOC Sues Pa. Health System Over Disability Discrimination
September 24, 2021
QVC Ducks Antitrust Claim In Suzanne Somers Diet Pill Row
September 24, 2021
Philadelphia Jury Clears J&J In Talc Cancer Case
September 23, 2021
Pa. Justice Casts Appeal As Bid To Limit Med Mal Theories
September 23, 2021
Non-Atty's Med Mal Work Required Warning, Pa. Justice Says
September 17, 2021
Pa. Court Is Asked For Hearing On 14-Minute Med Mal Verdict